IPCA LABORATORIES
|
The Current P/S Ratio of IPCA LABORATORIES is 4.98.
| Share Price | ₹1,986.0 | Sep 01,2026 |
| Market Cap | ₹50,383.6 Cr | |
| Sales-TTM | ₹10,125.6 Cr | TTM-Consolidated Results |
| Price/Sales | 4.98x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹50,383.6 Cr] as on Sep 01,2026
(/) Sales [ ₹10,125.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.98x ]
Thus, for IPCA LABORATORIES , the investors are currently willing to pay '4.98 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !
The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES
PS Ratio Performance Analysis for IPCA LABORATORIES
- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 4.11x.
- IPCA LABORATORIES 's operated at median p/e ratio of 4.24x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.
- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.
How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| IPCA LABORATORIES | 10,125.6 | 4.98 | 50,383.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.73 | 463,180.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.67 | 243,302.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.00 | 188,623.0 |
| CIPLA LTD | 28,324.4 | 4.04 | 114,554.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.94 | 97,741.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.61 | 97,467.0 |
| LUPIN LTD | 29,966.6 | 3.28 | 98,312.2 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.06 | 116,114.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.77 | 96,836.1 |
| LAURUS LABS LTD | 7,269.6 | 13.82 | 100,498.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.77x |
| Max industry PS | 21.67x |
| Median industry PS | 4.98x |
| Average industry PS | 7.63x |
You may also like the below Video Courses